Financials in GBp. Standardized financial statements.
A compact view of how Arix Bioscience plc turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue? | £112,000 | £340,000 | £477,000 | £506,000 | £1.33M | £1.86M |
| Revenue Growth? | -67.1% | -28.7% | -5.7% | -61.9% | -28.5% | 0.0% |
| Cost of Revenue? | £0 | £0 | £0 | £0 | £0 | £0 |
| Gross Profit? | £112,000 | £340,000 | £477,000 | £506,000 | £1.33M | £1.86M |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | £5.41M | £4.80M | £7.79M | £12.50M | £15.03M | £14.64M |
| Operating Income? | £25.48M | £50.95M | -£142.44M | £46.65M | £40.80M | -£3.59M |
| EBITDA? | £25.70M | £51.15M | -£142.11M | £47.09M | -£64.37M | -£17.82M |
| Income Before Tax | -£27.58M | -£61.08M | £126.30M | -£75.57M | £42.76M | -£7.69M |
| Income Tax Expense | -£4,000 | £112.03M | -£268.74M | -£5.88M | £5.88M | -£221,000 |
| Net Income? | -£27.57M | -£173.11M | £395.04M | -£69.69M | £36.88M | -£7.47M |
| EPS? | £-0.21 | £-1.27 | £2.78 | £-0.54 | £0.29 | £-0.09 |
| Diluted EPS? | £-0.21 | £-1.27 | £2.78 | £-0.54 | £0.29 | £-0.09 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality